New analysis shows high-dose, once-daily Enerzair Breezhaler cut asthma exacerbation rates by 21% (moderate or severe) and 31% […]
Development of SPOR-COV is supported by a grant from Innovate UK
Updated Date: Fri, 28 Aug 2020 00:00:00 EDT
Updated Date: Fri, 28 Aug 2020 00:00:00 EDT
Updated Date: Fri, 28 Aug 2020 00:00:00 EDT
Updated Date: Fri, 28 Aug 2020 00:00:00 EDT
Updated Date: Fri, 28 Aug 2020 00:00:00 EDT
Akebia crashes on vadadustat flop in larger anemia indication. Will AZ, FibroGen own the market? aliu Fri, 09/04/2020 […]
A COVID-19 vaccine in early November? ‘Extremely unlikely, but not impossible’: Warp Speed head Slaoui esagonowsky Fri, 09/04/2020 […]
